The European Antibody Congress 2026 is dedicated to global antibodies market, Antibody innovation, Antibody alternatives and advances, developmental success, antibody therapy approaches and Structure/Function Relationships.
Biotechs, Pharmaceutical Manufacturers, Academia / Research Institutes, Government / Regulatory Bodies, Equipment Manufacturers & Technology Providers, Contract Service Organisations (CMO and CSO), Legal Firms, Venture Capitalists and Consultants.
